Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis

By Yamada Ryo   Suzuki Akari   Yamamoto Kazuhiko  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 249-258

Future Medicine

Access to resources Recommend Favorite

Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis

By Alexiou Ioannis   Germenis Anastasios   Koutroumpas Athanasios   Kontogianni Anastasia   Theodoridou Katerina   Sakkas Lazaros  

Clinical Rheumatology, Vol. 27, Iss. 4, 2008-04 ,pp. : 511-513

Springer Publishing Company

Access to resources Recommend Favorite

Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α

By Onishi Sachiko   Yoshio Taku   Nagashima Takao   Minota Seiji  

Modern Rheumatology, Vol. 20, Iss. 5, 2010-10 ,pp. : 528-530

Springer Publishing Company

Access to resources Recommend Favorite

Anti-cyclic citrullinated peptide antibodies do not reflect self-reported disability and physical health in patients with rheumatoid arthritis of less than 5 years of duration

By Poulsen Chalotte   Jacobsen Søren   Frisch Morten   Frederiksen Kirsten   Johansen Christoffer  

Rheumatology International, Vol. 33, Iss. 11, 2013-11 ,pp. : 2763-2772

Springer Publishing Company

Access to resources Recommend Favorite

Association of Anti-cyclic Citrullinated Peptide Antibodies with Clinical and Radiological Disease Severity in Rheumatoid Arthritis

By  

Current Rheumatology Reviews, Vol. 10, Iss. 2, 2014-09 ,pp. : 136-143

Bentham Science Publishers

Access to resources Recommend Favorite